PFIZER - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.4

📉 Weak momentum and low volume limit intraday potential despite strong fundamentals and valuation.

📈 Positive

• 💰 ROCE of 21.6% and ROE of 16.4% reflect solid capital efficiency.
• 📊 P/E of 34.7 vs. Industry P/E of 33.1 suggests fair valuation.
• 📈 EPS of ₹177 and Debt-to-equity ratio of 0.01 indicate strong earnings and financial discipline.
• 📈 Quarterly PAT variation of +27.2% shows earnings growth.

⚠️ Limitation

• 📉 RSI at 40.2 and MACD at -1.08 indicate weak momentum.
• 📉 Price trading below DMA 50 (₹5,243) and near DMA 200 (₹5,102), showing resistance.
• 📉 Volume of 7,427 is well below 1-week average of 11,953, limiting intraday liquidity.
• 📉 PEG ratio of 22.0 suggests overvaluation relative to growth.

🚫 Company Negative News

• 📉 Slight drop in quarterly PAT from ₹198 Cr. to ₹192 Cr. may signal margin pressure.
• 📉 DII holding declined by 0.12%, showing domestic caution.

✅ Company Positive News

• 💊 Strong product pipeline and brand equity continue to support long-term growth.
• 📈 FII holding increased by 0.20%, indicating foreign investor confidence.

🏭 Industry

• 🧪 Industry P/E of 33.1 reflects moderate growth expectations in pharmaceuticals and healthcare.
• 📈 Demand for chronic therapies and branded generics supports sector fundamentals.

📌 Conclusion

• ⚠️ PFIZER is a cautious intraday candidate with strong fundamentals but weak technicals and low volume.
• 💡 Consider buying near ₹5,100–₹5,110 with target at ₹5,160–₹5,180 and stop-loss at ₹5,080.
• 📤 If already holding, exit if price crosses ₹5,175 with volume > 12,000 or RSI > 46.

I can also chart PFIZER’s intraday support and resistance zones to help visualize your trade setup.